Navigation Links
New generation asthma drug could improve metabolism
Date:6/5/2011

Formoterol, a new generation asthma medication, shows great promise for improving fat and protein metabolism, say Australian researchers, who have tested this effect in a small sample of men. The researchers presented their results on Saturday 4 June 2011 at The Endocrine Society's 93rd Annual Meeting in Boston.

The research team comprises members of Professor Ken Ho's lab from Sydney's Garvan Institute of Medical Research as well as Professor Ric Day, a clinical pharmacologist from St. Vincent's Hospital.

Study leader, endocrinologist Dr Paul Lee, focused his PhD research on how various hormones affect metabolism. Of central importance is a class of hormones called catecholamines, which regulate heart rate, metabolism and breathing.

Formoterol is a synthetic catecholamine, the metabolic effects of which have not previously been studied in people. Therapy doses given to animals, however, have shown that it stimulates metabolism without affecting the heart.

"We have known for a long time that catecholamine influences the way the body handles nutrients, in particular fat and protein," said Lee.

"The generation of drugs before formoterol was exploited in the livestock industry around 20 years ago to reduce the fat and increase the protein content of meat. Unfortunately, these older drugs also caused a faster heart rate."

"Formoterol is a new generation of this class of medication. It is highly selective for the kind of catecholamine receptors found in the lungs, and not those in the heart."

"The new drug is also more selective for a similar receptor found in muscle and fat. In theory at least, it should have beneficial metabolic effects like the older class of medication without affecting the heart."

Lee sourced the drug in its oral form, found the dose needed to give a metabolic effect, and gave it to 8 healthy men over a week.

"Energy metabolism increased by more than 10%, fat burning increased by more than 25%, while protein burning fell by 15%," he said.

"So although whole body metabolism increased, these men burned fat while reducing the burning of protein. That's a good thing because in the long run these effects may lead to a loss in fat mass and an increase in muscle.

"In this study, all 8 subjects tolerated the medication well without any significant increase in heart rate."

The next step will be to test the drug over a longer period in a larger sample of people to determine if the beneficial effects translate into improvement in body composition, health and function.


'/>"/>

Contact: Alison Heather
61-292-958-128
Research Australia
Source:Eurekalert

Related medicine news :

1. 30 Years Into the Epidemic, a Generation With HIV Comes of Age
2. Fetal programming of disease risk to next generation depends on parental gender
3. Columbia researchers work to prevent blindness from age-related macular degeneration
4. Targeted regeneration could be key to boosting coalfield communities
5. Mayo Clinic finds new genetic cause of neurodegeneration
6. In vivo RNAi screening identifies new regulators of liver regeneration
7. AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards
8. Mothers obesity may lead to infertility in the next generation
9. LRI awards wide-ranging research grants to drive next generation of scientific discovery in lupus
10. BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer
11. In search of cancers common ground: A next-generation view
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology: